Cellogen Therapeutics is a Delhi-based cell and gene therapy company founded by clinicians, developing indigenous CAR-T therapies and gene-editing solutions with GMP-compliant manufacturing aimed at making advanced oncology treatment affordable in India.
1StartupFox story
2021Founded
Biotechnology(Cell Therapy)Sector
May 2026Latest coverage
Funding
Cellogen Therapeutics has raised $2.4M across 1 disclosed round, most recently a Growth round in May 2026.
$2.4MRaised
Growth roundLatest round · May 2026
1Event
Chart appears once 2 more funding rounds are recorded — below that a chart shows less than the table does.
May 2026Growth round$2.4M (₹20 crore)Kotak Alternate Asset Managers (Kotak Life Sciences Fund I)StartupFox ↗
Cellogen Therapeutics is a Delhi-based cell and gene therapy company founded by clinicians, developing indigenous CAR-T therapies and gene-editing solutions with GMP-compliant manufacturing aimed at making advanced oncology treatment affordable in India.
Who founded Cellogen Therapeutics?
Cellogen Therapeutics is associated with Dr. Gaurav Kharya, Dr. Tanveer Ahmad.
How much funding has Cellogen Therapeutics raised?
Cellogen Therapeutics has raised $2.4M across 1 disclosed round. The most recent was a $2.4M Growth round in May 2026.
Who are Cellogen Therapeutics's investors?
Disclosed investors in Cellogen Therapeutics include Kotak Alternate Asset Managers (Kotak Life Sciences Fund I).
What is the latest news on Cellogen Therapeutics?
The most recent StartupFox coverage is “Cellogen Therapeutics Raises ₹20 Crore From Kotak Alts to Build an Indigenous CAR-T Cell Therapy Supply Chain” (18 May 2026). All stories are listed on this page.